Molecular markers demonstrate diagnostic and prognostic value in the evaluation of myelodysplastic syndromes in cytopenia patients

被引：3

作者：

He, Rong ^{[1
]}

Chiou, Jonathan ^{[2
]}

Chiou, Allison ^{[3
]}

Chen, Dong ^{[1
]}

Chen, Constance P. ^{[4
]}

Spethman, Caroline ^{[5
]}

Bessonen, Kurt R. ^{[1
]}

Oliveira, Jennifer L. ^{[1
]}

Nguyen, Phuong L. ^{[1
]}

Reichard, Kaaren K. ^{[1
]}

Hoyer, James D. ^{[1
]}

Althoff, Simon D. ^{[1
]}

Roh, Dana J. ^{[1
]}

Miller, Mechelle A. ^{[1
]}

Yuan, Ji ^{[1
]}

Olteanu, Horatiu ^{[1
]}

Begna, Kebede ^{[6
]}

Tefferi, Ayalew ^{[6
]}

Alkhateeb, Hassan ^{[6
]}

Patnaik, Mrinal M. ^{[6
]}

Litzow, Mark R. ^{[6
]}

Al-Kali, Aref ^{[6
]}

Viswanatha, David S. ^{[1
]}

机构：

[1] Mayo Clin, Coll Med, Div Hematopathol, Rochester, MN 55905 USA

[2] Dartmouth Coll, Hanover, NH USA

[3] Wellesley Coll, Wellesley, MA USA

[4] Univ Notre Dame, Coll Sci, Notre Dame, IN 46556 USA

[5] Univ Nebraska, Sch Med, Omaha, NE 68198 USA

[6] Mayo Clin, Coll Med, Div Hematol, Rochester, MN USA

来源：

BLOOD CANCER JOURNAL | 2022年 / 12卷 / 01期

关键词：

CLONAL HEMATOPOIESIS; MUTATIONS; MDS; RISK;

D O I：

10.1038/s41408-022-00612-w

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：4

共 50 条

[11] Evaluation of apoptosis as a prognostic factor in myelodysplastic syndromes
Shimazaki, K
Ohshima, K
Suzumiya, J
Kawasaki, C
Kikuchi, M
BRITISH JOURNAL OF HAEMATOLOGY, 2000, 110 (03) : 584 - 590
[12] Update on genetic and molecular markers associated with myelodysplastic syndromes
Valent, Peter
Wieser, Rotraud
LEUKEMIA & LYMPHOMA, 2009, 50 (03) : 341 - 348
[13] The Multifaceted Nature of Myelodysplastic Syndromes: Clinical, Molecular, and Biological Prognostic Features
Greenberg, Peter L.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2013, 11 (07): : 877 - 885
[14] Diagnostic and prognostic significance of cytogenetics in adult primary myelodysplastic syndromes
Jotterand, M
Parlier, V
LEUKEMIA & LYMPHOMA, 1996, 23 (3-4) : 253 - 266
[15] Improving Prognostic Tools for Patients With Myelodysplastic Syndromes
Garcia-Manero, Guillermo
MAYO CLINIC PROCEEDINGS, 2018, 93 (10) : 1340 - 1342
[16] Evaluation of the Prognostic Significance of Eosinophilia and Basophilia in a Larger Cohort of Patients With Myelodysplastic Syndromes
Wimazal, Friedrich
Germing, Ulrich
Kundi, Michael
Noesslinger, Thomas
Blum, Sabine
Geissler, Philipp
Baumgartner, Christian
Pfeilstoecker, Michael
Valent, Peter
Sperr, Wolfgang R.
CANCER, 2010, 116 (10) : 2372 - 2381
[17] Validation of the Revised International Prognostic Scoring System for Patients with Myelodysplastic Syndromes
Savic, Aleksandar
Marisavljevic, Dragornir
Kvrgic, Vanja
Stanisavljevic, Natasa
ACTA HAEMATOLOGICA, 2014, 131 (04) : 231 - 238
[18] Clinical impact of genetic and molecular markers in myelodysplastic syndromes (MDS)
Peter Valent
memo - Magazine of European Medical Oncology, 2009, 2 (Suppl 1) : 13 - 17
[19] Clinical impact of genetic and molecular markers in myelodysplastic syndromes (MDS)
Valent, Peter
MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2009, 2 : 13 - 17
[20] Validation and improvement of the molecular international prognostic scoring system in Chinese patients with myelodysplastic syndromes
Huang, Nanfang
Song, Yang
Wu, Lingyun
He, Qi
Zhang, Zheng
Guo, Juan
Xu, Feng
Chang, Chunkang
Li, Xiao
ANNALS OF HEMATOLOGY, 2025, 104 (01) : 193 - 206

← 1 2 3 4 5 →